Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix

European Journal of Gynaecological Oncology

Volumn 17, Issue 4, 1996, Pages 283-285

  Bar, J K ^a   Markowska, J ^a   Harlozinska A ^a   Sedlaczek, P ^a   Nowak, M ^a   Roszak, A ^a   Janina, M ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cancer of the cervix; HPV; Oncoproteins p21; p53

Indexed keywords

ONCOPROTEIN; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; PAPILLOMA VIRUS; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; VIRUS INFECTION;

FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; ONCOGENE PROTEIN P21(RAS); PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0029746230     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Choo K. B., Pan C. C., Han S. H.: Virology, 1987, 161, 259.
2. Crook T., Wrede D., Vousden K. H.: Oncogene, 1991, 6, 873.
3. Crook T., Wrede D., Tidy J. A. et al: Lancet, 1992, 339, 1070.
4. Dyson N., Howley P. M., Munger K., Harlo W. E.: Science, 1989, 243, 934.
5. Harris C. C.: Cancer Res., 1991, 51, 5023.
6. Ono H., Furihata M., Matsuoka A. et al.: Oncol. reports, 1994, 1, 831.
7. Paquette R. L., Lee Y. Y., Wilczyński S. P. et al.: Cancer, 1993, 72, 1272.
8. Scheffner M., Wernerss B. A., Hnibregste J. M. et al.: Leu, 1990, 63, 1129.
9. Schwarz E., Trese U. K., Gissmann L. et al.: Nature, 1985, 314: 111.
10. Tamaka T., Slamon D. J., Battifora H., Cline M. J.: Cancer Res., 1986, 46, 1465.
11. Tamaka Y., Slamon D. J., Shimada H. et al.: Cancer, 1991, 681, 1296.
12. Yaginuma Y., Westphal H.: Cancer Res., 1991, 51, 6506.